|
|
|
|
||
Breaking now on CNBC... GSK new initiativesCeo On now.. Talking about refocusing on R&D and specific focus on vaccine business growth. Very interesting... For clarity, NO REFERENCE at all to NVAX, but a very interesting overall announcement of their refocusing as it relates to the industry as a whole. |
return to message board, top of board |